Search Results - "Mateu, M. Muñoz"

New clinical trials regulation in Spain: analysis of royal decree 1090/2015 by Martin Jimenez, M., Calvo Ferrandiz, A., Aparicio Urtasun, J., Garcia-Campelo, R., Gonzalez-Flores, E., Lazaro Quintela, M., Muñoz Mateu, M., Rodriguez Sanchez, C. A., Santaballa Bertran, A., Sepulveda Sanchez, J. M., Vera Garcia, R., Virizuela Echaburu, J. A., Segui Palmer, M. A.

“…The coming into force of Directive 2001/20/EC represented a step forward in harmonising clinical trial regulation in European countries, guaranteeing a uniform…”
Get full text

116P Real-world and in silico incidence of fibroblast growth factor receptor (FGFR) 1-4 molecular alterations across multiple cancer types by Angelats, L., Indacochea, A., Ruiz, I. Victoria, Moreno, D., Bentz, P. Sole, Mellado, B., Pineda, E., Garcia, L. Gaba, Mateu, M. Muñoz, Vidal, M., Saurí, T., Esposito, F.M., Ferrer, L., Martínez-Sáez, O., Basté, N., Ortega, V., Jolis, L., Mezquita, L., Prat, A., Garcia-Corbacho, J.

Get full text

203P Randomized study of single-agent metronomic versus weekly oral vinorelbine (VNR) as first-line chemotherapy in patients with HR+/HER2- advanced breast cancer by Cazzaniga, M.E., Martinez Jañez, N., Kukielka-Budny, B.D., Ulanska, M., Bourgeois, H., Muñoz Mateu, M., Morales Murillo, S., Bayo, J., Cortesi, L., Pinter, T., Palacova, M., Cherciu, N., Petru, E., Ettl, J., De Almeida, C., Raymond, R., Villanova, G.R., Thanh Minh, C. Ta, Rodrigues, A.C.F., Freyer, G.

Get full text

275O Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM) by Mueller, V., Paplomata, E., Hamilton, E.P., Zelnak, A., Fehrenbacher, L., Jakobsen, E.H., Curtit, E., Boyle, F., Brix, E.H., Brenner, A.J., Ferrario, C., Munoz-Mateu, M., Arkenau, T., Gelmon, K.A., Cameron, D., Curigliano, G., DeBusk, K., Ramos, J., An, X., Wardley, A.M.

Get full text

HER2-positive breast cancer cells percentage and progression to trastuzumab treatment in metastatic patients by García-García, Y., Martínez-Fernández, A., Muñoz Mateu, M., Fernández-Ruiz, P., García-Albéniz, X., Mármol-Casas, M., Domingo-Doménech, J., Pineda-Losada, E., Visa-Turmo, L., Gascón Vilaplana, P.

“…Abstract only 11510 Background: Immunohistochemistry (IHC) assay for HER2 in breast cancer (BC) identify patients (pts) who are at benefit from Trastuzumab (T)…”
Get full text

548P Molecular pre-screening using comprehensive gene panels offered by clinical trials (CT) by Ruiz, I. Victoria, Moreno, D., Sole, P., Gonzalez, B. Mellado, Pineda, E., Gaba, L., Sauri, T., Mileo, L. Ferrer, Orrillo, M., Maurel, J., Oliveres, H., Munoz-Mateu, M., Losada, M.J. Vidal, Saez, O. Martinez, Chic, N., Baste, N., Segarra, N. Vinolas, Reyes, R., Prat, A., Garcia-Corbacho, J.

Get full text

Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009−05 study by Martin, M., Martinez, N., Ramos, M., Calvo, L., Lluch, A., Zamora, P., Munoz-Mateu, M., Caronia, D., Carrasco, E. M., Garcia Saenz, J. Á., Casado, A., Chacón, I., Hernando, B., Ruiz-Borrego, M., Gonzalez-Neira, A.

“…Abstract only…”
Get full text

Trastuzumab plus capecitabine with or without pertuzumab in patients with HER2-positive MBC whose disease has progressed during or following trastuzumab-based therapy for first-line metastatic disease: A multicenter, randomized, two-arm, phase II study (PHEREXA) by Munoz-Mateu, M., Urruticoechea, A., Separovic, R., Erfán, J., Bachelot, T. D., Canon, J., Kovalenko, N., Staroslawska, E., Pikó, B., Veyret, C., Pribylova, O., Ciule, D. L., Ratnayake, J., Das, S., Mayne, K., Ross, G.

“…Abstract only…”
Get full text

Multicentric, observational, transversal study to describe the clinical profile of patients with metastatic breast cancer (MBC) treated with first-line bevacizumab (TRANSBREAST): Preliminary results by Guirado-Risueño, M., Perez Manga, G., Rifa, J., Perez Carrion, R. M., García López, M. J., Velasco, A., Oltra Ferrando, A., Barrajon, E., Lopez-Vivanco, G., Munoz-Mateu, M.

“…Abstract only…”
Get full text